Your activity: 213 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Smith-Lemli-Opitz syndrome: Biosynthetic pathways

Smith-Lemli-Opitz syndrome: Biosynthetic pathways
The effect of Smith-Lemli-Opitz syndrome on the biosynthesis of estriol by the fetalplacental unit A mutation of the enzyme C7-reductase in the fetus prevents the conversion of 7-dehydrocholesterol (DHC) to cholesterol. This blockade leads to impaired biosynthesis of estriol. Conversion of 7-DHC to cholesterol by the mother, who is a carrier of the mutation and is not affected, is not impaired.
DHEAS: dehydroepiandrosterone sulfate.
Graphic 71463 Version 5.0